These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 2623191)

  • 1. Clearance of vasoactive intestinal polypeptide (VIP) in the porcine pulmonary circulation.
    Hvidsten D; Lindsetmo RO; Røkke O; Jenssen TG; Burhol PG; Revhaug A
    Regul Pept; 1989 Dec; 26(3):267-75. PubMed ID: 2623191
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of enalapril on vasoactive intestinal peptide metabolism and tissue levels.
    Duggan KA; Ye VZ
    Eur J Pharmacol; 1998 Sep; 358(1):25-30. PubMed ID: 9809865
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Degradation of vasoactive intestinal peptide by isolated, ventilated, and perfused rat lungs.
    Bernhard W; Bothe-Sandtfort E; Koop H; Cassel W; Von Wichert P
    Eur J Clin Invest; 1989 Dec; 19(6):506-13. PubMed ID: 2515970
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vasoactive intestinal polypeptide potentiates the hypoxemia-induced decrease in splanchnic circulation in the rat.
    Grisoni ER; Brown-Armstrong E; Kalhan SC
    J Pediatr Surg; 1988 Dec; 23(12):1193-7. PubMed ID: 3236187
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Infusion of vasoactive intestinal polypeptide in man: pharmacokinetics and effect on gastric acid secretion.
    Holm-Bentzen M; Christiansen J; Petersen B; Fahrenkrug J; Schultz A; Kirkegaard P
    Scand J Gastroenterol; 1981 Apr; 16(3):429-32. PubMed ID: 16435487
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The vasoactive intestinal peptide receptor turnover in pulmonary arteries indicates an important role for VIP in the rat lung circulation.
    Petkov V; Gentscheva T; Schamberger C; Haberl I; Artl A; Andreae F; Mosgoeller W
    Ann N Y Acad Sci; 2006 Jul; 1070():481-3. PubMed ID: 16888213
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatic metabolism of vasoactive intestinal polypeptide (VIP) in the rat.
    Brook CW; Sewell RB; Shulkes A; Smallwood RA
    Regul Pept; 1988 Apr; 20(4):311-22. PubMed ID: 3368582
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma levels of substance P, neuropeptide Y and vasoactive intestinal polypeptide in patients with chronic tension-type headache.
    Ashina M; Bendtsen L; Jensen R; Ekman R; Olesen J
    Pain; 1999 Dec; 83(3):541-547. PubMed ID: 10568863
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of VPAC1 and VPAC2 in VIP mediated inhibition of rat pulmonary artery and aortic smooth muscle cell proliferation.
    St Hilaire RC; Murthy SN; Kadowitz PJ; Jeter JR
    Peptides; 2010 Aug; 31(8):1517-22. PubMed ID: 20452385
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radioimmunoassay of vasoactive intestinal polypeptide (VIP) in plasma.
    Fahrenkrug J; Schaffalitzky de Muckadell OV
    J Lab Clin Med; 1977 Jun; 89(6):1379-88. PubMed ID: 325156
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased plasma levels of vasoactive intestinal polypeptide in pigs during endotoxinaemia.
    Revhaug A; Lygren I; Lundgren TI; Andersen OK; Burhol PG; Giercksky KE
    Eur Surg Res; 1985; 17(2):75-82. PubMed ID: 3884342
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circulating endogenous vasoactive intestinal polypeptide (VIP) in patients with uraemia and liver cirrhosis.
    Henriksen JH; Staun-Olsen P; Borg Mogensen N; Fahrenkrug J
    Eur J Clin Invest; 1986 Jun; 16(3):211-6. PubMed ID: 3089817
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gastric and intestinal release of vasoactive intestinal polypeptide in the milk-fed lamb.
    Reid AM; Shulkes A; Titchen DA
    Regul Pept; 1985 Sep; 12(1):43-50. PubMed ID: 4070686
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of bile salts on the plasma concentration of immunoreactive vasoactive intestinal polypeptide in man.
    Matsumura M; Saito S
    Endocrinol Jpn; 1989 Feb; 36(1):15-21. PubMed ID: 2731483
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vasoactive intestinal polypeptide (VIP) in children with neural crest tumours.
    Scheibel E; Rechnitzer C; Fahrenkrug J; Hertz H
    Acta Paediatr Scand; 1982 Sep; 71(5):721-5. PubMed ID: 6295059
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fetal metabolism and placental transfer of vasoactive intestinal peptide in sheep.
    Shulkes A; Henderson T; Hardy KJ
    Biol Reprod; 1987 Aug; 37(1):1-5. PubMed ID: 3651537
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vasoactive intestinal peptide causes nitric oxide-dependent pulmonary vasodilation in isolated rat lung.
    Iwabuchi S; Ono S; Tanita T; Koike K; Fujimura S
    Respiration; 1997; 64(1):54-8. PubMed ID: 9044476
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Systemic and cavernous plasma levels of vasoactive intestinal polypeptide during sexual arousal in healthy males.
    Becker AJ; Uckert S; Stief CG; Scheller F; Knapp WH; Machtens SA; Kuczyk MA; Jonas U
    World J Urol; 2002 May; 20(1):59-63. PubMed ID: 12088193
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide on pancreatic, hepatic and duodenal mucosal bicarbonate secretion in the pig.
    Glad H; Ainsworth MA; Svendsen P; Fahrenkrug J; Schaffalitzky de Muckadell OB
    Digestion; 2003; 67(1-2):56-66. PubMed ID: 12743442
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Release of oxytocin and vasopressin by intracerebroventricular vasoactive intestinal polypeptide.
    Bardrum B; Ottesen B; Fahrenkrug J; Fuchs AR
    Endocrinology; 1988 Nov; 123(5):2249-54. PubMed ID: 3168920
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.